Oncolytics Biotech Inc. (USA)


Stock Update (NASDAQ:ONCY): Oncolytics Biotech, Inc. (USA) Announces Start of Enrollment in Phase 1b Study of Multiple Myeloma Looking at REOLYSIN® in Combination with Bortezomib

Oncolytics Biotech, Inc. (USA) (OTCMKTS:ONCYF) announced that enrollment has commenced in a Phase Ib study of REOLYSIN® combined with standard doses of bortezomib (Kyprolis®) …

Company Update (NASDAQ:ONCY): Oncolytics Biotech, Inc. (USA) Announces Receipt of Qualification for Trading on the OTCQX and Nasdaq Notice of Delisting

Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY) announced that it has received notification from OTC Markets Group Inc.

Company Update (NASDAQ:ONCY): Oncolytics Biotech, Inc. (USA) Announces Phase 1b Study in Advanced Pancreatic Cancer

Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY) announced that, following submission to the U.

Stock Update (NASDAQ:ONCY): Oncolytics Biotech, Inc. (USA) Collaborators Present Data from Clinical Study in Multiple Myeloma

Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY) announced that Dr.

Stock Update (NASDAQ:ONCY): Oncolytics Biotech, Inc. (USA) Collaborators to Present Survival Data from REO 016 Study in Non-Small Cell Lung Cancer

Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY) announced the encore presentation of findings from a post-hoc analysis examining the effects of icosapent ethyl (Vascepa®) on Apolipoprotein …

Company Update (NASDAQ:ONCY): Oncolytics Biotech, Inc. (USA) Announces Completion of Enrollment in Randomized Phase II Non-Small Cell Lung Cancer Study

Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY) announced that enrollment has been completed in a randomized Phase II study of REOLYSIN® in patients with previously treated advanced …

Company Update (NASDAQ:ONCY): Oncolytics Biotech, Inc. (USA) Announces Voting Results from its Annual Meeting of Shareholders

Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY) announced the voting results from its Annual Meeting of Shareholders held on Monday June 8th, 2015.

Canaccord Maintains Buy on Oncolytics Biotech, Inc. (USA) Following Updated Guidance on Reolysin

Canaccord Genuity analyst Neil Maruoka came out with his views on Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY), after the company provided updated guidance on its planned registration …

Stock Update (NASDAQ:ONCY): Oncolytics Biotech, Inc. (USA) Announces Extension to Regain Compliance with Nasdaq’s Minimum Bid Price Rule

Oncolytics Biotech, Inc. (USA) (NASDAQ:ONCY) announced that it has received a letter from the NASDAQ OMX Group (“Nasdaq”) determining that the Company is …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts